Progressing new medicine development to help make the world healthier is a key driver why Clintec was founded by Dr Rabinder Buttar. Additionally it is a cornerstone of why the Executive Team continue to pursue the work we are doing.
Earlier this month exciting industry news from South Africa emerged which showcased a recent success in the treatment of Multi-Drug Resistant (MDR) and Extensively Drug Resistant (EDR) tuberculosis (TB), a life-threatening condition affecting millions of people. According to the World Health Organisation (WHO) over 10.4 million people suffered from TB in 2015 highlighting the international scale of this illness. Furthermore, the WHO estimates that less than 1 in 3 people with XDR-TB and less than half with MDR-TB are successfully treated. Please read the positive news regarding outcomes from two separate trials which are helping to bring hope and successful treatment paths for patients with MDR -TB and XDR-TB, potentially leading to thousands of lives being saved.